The AAPS Journal, an official journal of the American Association of Pharmaceutical Scientists, publishes state-of-the art papers that present innovative and relevant research spanning various areas of the pharmaceutical sciences impacting human and veterinary therapeutics.

Journal information

Editor-in-Chief
  • Ho-Leung Fung
Publishing model
Hybrid (Transformative Journal). Learn about publishing Open Access with us

Journal metrics

3.737 (2019)
Impact factor
4.110 (2019)
Five year impact factor
437,715 (2020)
Downloads

Latest articles

Journal updates

  • Open Call for Papers

    The AAPS Journal is pleased to announce an Open Call for Papers for the new theme issue Celebrating Women in the Pharmaceutical Sciences! For more information and to submit your work, visit The AAPS Journal webpage.

  • COVID-19 and impact on peer review

    As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

  • The AAPS Journal High Impact Article Award

    The AAPS Journal High Impact Article Award Recognizing an article published in the last two years in The AAPS Journal that is judged exceptional by the editors for its impact on the pharmaceutical sciences. 

    Awardee/Corresponding Author: Volker Lauschke, Ph.D., M.B.A., Karolinska Institutet Co-Authors: ALili Milani, Ph.D. and Magnus Ingelman-Sundberg, Ph.D.

    Watch the video here.

  • Announcing new Editor-in-Chief of AAPS Open: Dr. Andrea Allmendinger

    AAPS Open is proud to announce new Editor-in-Chief Dr. Andrea Allmendinger. Dr. Allmendinger obtained her PhD in Pharmaceutical Technology from the University of Basel and joined the Pharmaceutical Development department of Roche/Genentech in Basel in 2013, where she is responsible for formulation and process development for clinical Phase I-III projects and commercial transfer activities for both large molecules and for synthetic drugs.

View all updates

Societies, partners and affiliations

Subscribe

eJournal
$79.00
Note this is only the net price. Taxes will be calculated during checkout.
  • Immediate online access with complete access to all articles starting 1997
  • Downloadable in PDF format
  • Subscription expires 12/31/2021

About this journal

Electronic ISSN
1550-7416
Co-Publisher information
American Association of Pharmaceutical Scientists
Abstracted and indexed in
  1. CNKI
  2. Chemical Abstracts Service (CAS)
  3. Dimensions
  4. EBSCO Biomedical Reference Collection
  5. EBSCO Discovery Service
  6. EMBASE
  7. Google Scholar
  8. Institute of Scientific and Technical Information of China
  9. Japanese Science and Technology Agency (JST)
  10. Journal Citation Reports/Science Edition
  11. Medline
  12. Meta
  13. Naver
  14. OCLC WorldCat Discovery Service
  15. ProQuest-ExLibris Primo
  16. ProQuest-ExLibris Summon
  17. Reaxys
  18. SCImago
  19. SCOPUS
  20. Science Citation Index Expanded (SciSearch)
  21. TD Net Discovery Service
  22. UGC-CARE List (India)
Copyright information

Rights and permissions

Springer policies

© American Association of Pharmaceutical Scientists